HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of Alzheimer's disease: hopes and reality.

Abstract
The relative failure of symptomatic therapeutic trials for Alzheimer's disease using non-selective cholinergic agonists brings about the need for longitudinal studies with parallel designs aimed at disease stabilization, using trophic substances or amyloid suppressors.
AuthorsS Gauthier, L Gauthier, R Bouchard, R Quirion, S Sultan
JournalThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (Can J Neurol Sci) Vol. 18 Issue 3 Suppl Pg. 439-41 (Aug 1991) ISSN: 0317-1671 [Print] England
PMID1933695 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Parasympathomimetics
Topics
  • Alzheimer Disease (drug therapy, psychology)
  • Clinical Trials as Topic (methods)
  • Humans
  • Parasympathomimetics (therapeutic use)
  • Prognosis
  • Psychiatric Status Rating Scales
  • Research Design
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: